Oxurion NV - Data from a Phase 1/2 Clinical Study evaluating THR-317 (anti-PlGF) for DME presented at 2019 FLORetina Meeting (6.6.2019)

06 juni 2019

Oxurion (ThromboGenics)

Bijlagen

Oxurion NV - Da...